Spinal Sufentanil for Obstetric Analgesia

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

June 15, 2016

Primary Completion Date

August 25, 2016

Study Completion Date

June 21, 2017

Conditions
Labor Pain
Interventions
PROCEDURE

Spinal analgesia

Spinal analgesia (SA) was provided by a resident or specialist anaesthesiologist with the patient in a sitting or a recumbent position. A pencil-point needle, primarily 27 G (0.4 mm), otherwise 25 G (0.5 mm), was used for transdermal intrathecal administration of 2.0 ml of sufentanil 5 µg/ml (Sufenta®, Janssen-Cilag AB, Solna, Sweden) at low-lumbar level. Blood pressure was recorded before, immediately after, and at five-minute intervals for 20 minutes after the block. Any decrease in systolic pressure to \<100 mmHg or a decrease \>20% from the baseline level despite infusion of crystalloid was defined to indicate maternal hypotension.

All Listed Sponsors
lead

Lund University

OTHER

NCT04141527 - Spinal Sufentanil for Obstetric Analgesia | Biotech Hunter | Biotech Hunter